DEA Proposes New Import, Export Restrictions for para-Methoxymethamphetamine
The Drug Enforcement Administration is proposing to list para-methoxymethamphetamine (PMMA), a drug similar to methylenedioxymethamphetamine (MDMA) that is also sold as “ecstasy,” as a schedule I substance under the Controlled Substances Act. “If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess), or propose to handle PMMA,” DEA said. Comments are due June 15.
Sign up for a free preview to unlock the rest of this article
Export Compliance Daily combines U.S. export control news, foreign border import regulation and policy developments into a single daily information service that reliably informs its trade professional readers about important current issues affecting their operations.
(Federal Register 05/15/20)